Clinical Trials Browser

Phase 2 × Dendritic Cell Sarcoma, Interdigitating × 30 days × Clear all

Dendritic Cell Sarcoma, Interdigitating

NCT03349450 2026-05-06

SPiReL

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Recurrence, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Clinical Trials

CAR-T Followed by Bispecific Antibodies

SPiReL